MARKET

AZN

AZN

AstraZeneca
NYSE
164.21
-1.94
-1.17%
After Hours: 164.21 0 0.00% 19:30 09/29 EDT
OPEN
165.09
PREV CLOSE
166.15
HIGH
166.47
LOW
163.24
VOLUME
3.37M
TURNOVER
--
52 WEEK HIGH
209.11
52 WEEK LOW
152.66
MARKET CAP
254.70B
P/E (TTM)
24.55
1D
5D
1M
3M
1Y
5Y
1D
AstraZeneca Secures $2 Billion Summit Therapeutics Oncology Partnership, Bolstering GI Cancer Pipeline and Supporting Buy Rating on AZN
TipRanks · 10h ago
AstraZeneca submits NDA for savolitinib + Tagrisso for NSCLC
Seeking Alpha · 21h ago
Summit Therapeutics: Stronger Balance Sheet Helps, But It Does Not De-Risk Ivonescimab
Seeking Alpha · 21h ago
Bernstein Remains a Buy on AstraZeneca (AZN)
TipRanks · 22h ago
A $2 Billion Reason Why AstraZeneca Stock Is Down Today
Barchart · 1d ago
Morning Movers: Summit Therapeutics jumps after AstraZeneca investment
TipRanks · 1d ago
AstraZeneca (AZN) Receives a Buy from Jefferies
TipRanks · 1d ago
Why Is Summit Therapeutics Stock (SMMT) Soaring in Premarket Today, Sept. 29?
TipRanks · 1d ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca PLC (US) stock information, including NYSE: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.